Therefore, we generated a new humanized skin graft model where HLA-A*02+ tumors were exposed to HPV16 E7 antigens and human immune cells that could then mount an anti-tumor response upon vaccination with a therapeutic DNA HPV vaccine. The gene discussed is HLA-A; the disease is neoplasm.